INTRODUCTION {#S0001}
============

Renal failure is a condition in which the kidneys are unable to adequately filter toxins and waste products from the blood. It is described as a decrease in glomerular filtration rate (GFR) and can be determined by measuring the plasma clearance of different glomerular filtration markers like inulin, ethylene-diamine-tetra-acetic-acid, and etc.^[@CIT0001],\ [@CIT0002]^ Renal failure classified into two forms of acute and chronic. Acute renal failure (ARF) is characterized by abrupt decline in renal filtration function.^[@CIT0003]^ It is typically marked by increase in BUN and serum ceratinine and decreased urine production.^[@CIT0004]^ For simplicity, the cause of ARF is divided into sources of renal injury such as pre-renal, intrinsic and post-renal. Pre renal ARF is the limitation of blood flow to the kidney. The common symptoms in the outpatient setting are vomiting, diarrhea, poor fluid intake, fever, use of diuretics and heart failure. Intrinsic ARF can be result from damage to kidney tubules, interstitium, and glomeruli, kidney tubules, or interstitium. Post renal ARF is due to obstruction of both or one urinary tracts.^[@CIT0005]^ ARF is a devastating clinical problem in the surgical patients. The rate of mortality depends on underlying disease and it is much more in intensive care unit setting. Approximately 50% to 80% of patients in ICU died from ARF.^[@CIT0003]--[@CIT0005]^

Chronic renal failure (CRF) is a progressive loss in kidney function over a period of time. It is identified by higher amount of creatinine and lower glomerular filtration rate. In the early stages, there may be no symptoms but it gets worse gradually. The final stage of chronic kidney disease is an irreversible debilitating condition of kidney which requires intensive treatments of dialysis or transplantation.^[@CIT0006]^ The adverse outcome of CRF are kidney failure, cardiovascular disease (CVD), and premature death.^[@CIT0007]^ Different characteristics can be effective to distinguish chronic from acute renal failure. The primary differences between acute and chronic renal failure are the cause and duration of them. Duration of ARF varies from patient to patient and is affected by different factors such as the cause of the kidney problem. CRF is a lifelong problem and it tends to get worse over months or years. Presence of disease in last few months, normochromic anemia, growth failure, a history of nephritic or nephritic syndrome, high blood pressure, diabetes mellitus, kidney stone, glomerulonephritis and infection make chronic renal failure more likely.^[@CIT0008],\ [@CIT0009]^ Acute renal failure has a sudden onset and can occur as a complication of medical conditions, surgery, or trauma. Hypovolemia due to hemorrhage or severe dehydration, hypotension, congestive heart failure,sepsis, nephrotoxins, are also seen in patients with acute renal failure.^[@CIT0004],\ [@CIT0010]^

Red cell production due to the Erythropoietin deficiency is too low in CRF and causes development of anemia in this situation.^[@CIT0011]^ Anemia is also seen in patients with acute renal failure but the exact relationship between them remained unclear.^[@CIT0012]^ In addition to anemia, platelet count also seems to be affected by renal disorder too. The exact pattern of platelet count in patients with renal failure is controversial but several studies revealed the decrease in platelet count in renal failure.^[@CIT0013]^

The purpose of this investigation is to evaluate the effect of acute and chronic renal failure on severity of anemia and platelet count.

MATERIALS AND METHODS {#S0002}
=====================

This case-control study was conducted on 96 patients with acute renal failure and 36 patients with chronic renal failure from February to April 2012 as case groups and two groups of 97 and 82 individuals as controls. Ethical approve and patients consent statement were taken from everyone and the study was performed in central hospital of Iranshahr.

At first, all patients with proven renal failure were included in study then patients were divided in two groups of acute (\<3 month) and chronic (\>3month) based on disease duration.

Patients with especial established disorders such as endocrinopathies, anemia, and hepatosplenomegaly and also patients with use of certain drugs such as heparin were excluded from study. During the study, no patient had blood or blood components such as fresh frozen plasma (FFP) and platelet transfusion. In order to eliminate effects of sex and age on comparison between cases and control groups, age and sex were selected in each pair of groups as similar as possible.

Initially two separate blood samples were taken from each patient, 2 ml uncoagulated sample harvest for biochemical assay and EDTA anti coagulated whole blood sample for complete blood cell count.

Serum were used to determined level of blood urine nitrogen (BUN) and creatinine, and then complete blood count were done with EDTA anti coagulated samples by Sysmex ( kx 21 Japan).

Statistical analysis was done by SPSS software. Statistical independent t test was used to evaluate the significance of differences between two groups. P\<.05 was considered as significant change.

RESULTS {#S0003}
=======

In groups of patients with acute (49% male, 51% female) and chronic (75%male, 25%female) renal failure mean age were 58±15 and 60±11.5 years respectively. In control groups of acute (50% male, 50% female) and chronic (76%male, 24% female) renal failure mean ages were 59±12 and 60±12 years respectively.

The average level of BUN and creatinine in patients with acute renal failure were 89±21 mg/dl and 2.9±0.9 mg/dl and in control groups were 18±6 mg/dl and 1±0.4 mg/dl. In groups of chronic patients and control, the average of BUN and creatinine were 84±25 mg/dl and 13.2±6 and 15±7 mg/dl and 1±0.14 mg/dl.

Comparison between acute renal failure and the control group revealed that RBC count, hemoglobin amount and hematocrit level were significantly lower in the patient group than control group (P \< 0.001) ([Table 1](#T0001){ref-type="table"}).

###### 

Comparison of Hematological Indices between Patients with Acute Renal Failure and Healthy Individuals

  Index                       Number   Mean    Std. Deviation   P. value
  ----------------- --------- -------- ------- ---------------- ----------
  RBC (×10^9^/µL)   acute     96       4.2     0.72             \<0.0001
                    control   97       4.8     0.51             
  Hb (g/dL)         acute     96       12.2    2.04             \<0.0001
                    control   97       13.9    1.45             
  HCT (%)           acute     96       34.6    8.87             \<0.0001
                    control   97       41.7    3.36             
  MCV(fl)           acute     96       86.6    7.01             0.358
                    control   97       85.7    7.03             
  MCH(pg)           acute     96       28.5    2.81             0.310
                    control   97       29.3    7.11             
  MCHC(g/dl)        acute     96       32.8    1.51             0.028
                    control   97       33.4    1.64             
  RDW (%)           acute     96       8.2     2.79             0.094
                    control   97       7.6     2.15             
  PLT(×10^3^/µl)    acute     96       246.1   67.06            0.385
                    control   97       238.1   51.59            
  WBC(×10^3^/µl)    acute     96       13.7    1.11             0.058
                    control   97       13.3    1.22             

In patients with chronic renal failure, RBC count, hemoglobin and hematocrit level, MCHC and platelet count are significantly lower than the control group (P \< 0.05) but MCH and MCV levels are not significantly different between these two groups (P \> 0.05) ([Table 2](#T0002){ref-type="table"}).

###### 

Comparison of Hematological Indices between Patients with Chronic Renal Failure and Healthy Individuals

  Index                       Number   Mean    Std. Deviation   P. value
  ----------------- --------- -------- ------- ---------------- ----------
  RBC (×10^9^/µL)   chronic   36       4.3     0.86             0.0001
                    control   82       4.8     0.49             
  Hb (g/dL)         chronic   36       12      2.27             0.0001
                    control   82       14      1.37             
  HCT (%)           chronic   36       34.8    9.27             0.0001
                    control   82       41.9    3.21             
  MCV(fl)           chronic   36       84.8    10.08            0.403
                    control   82       86.2    6.68             
  MCH(pg)           chronic   36       27.6    4.23             0.134
                    control   82       29.5    7.20             
  MCHC(g/d)         chronic   36       32.4    2.08             0.008
                    control   82       33.4    1.62             
  RDW (%)           chronic   36       10.9    4.53             0.0001
                    control   82       7.5     2.19             
  PLT(×10^3^/µl)    chronic   36       172.4   90.44            0.0001
                    control   75       239.4   56.928           
  WBC(×10^3^/µl)    chronic   35       12.5    4.24             0.1
                    control   71       13.7    1.25             

DISCUSSION {#S0004}
==========

Renal failure is a condition due to inadequate removal of toxins and waste products by kidneys from the blood. It classified into two types of acute and chronic.^[@CIT0001],\ [@CIT0002]^ Acute renal failure (ARF) is characterized by an abrupt decrease in glomerular filtration rate (GFR) and also referred clinically as a sharp increase of the serum creatinine and BUN and decreased of the urine output.^[@CIT0004]^ Chronic renal failure (CRF) describes the gradual loss of kidney function with decrease in glomerular filtration rate and diagnosed by high level of creatinine.^[@CIT0006]^ Anemia due to the Erythropoietin deficiency is seen in CRF and ARF.^[@CIT0011]^ In addition to anemia, several studies showed the decrease of platelet count in renal failure.

We aimed to evaluate anemia situation and platelet count in patients with acute and chronic renal failure in comparison with normal individuals.

Our study revealed that some red blood cell indices including RBC count and Hb, HCT and MCHC levels were significantly lower in patient group in comparison with healthy non renal affected people(P \< 0.05) and anemia was considerable in patients with acute renal failure.

The study of Michele Hales in 1994 described the presence of anemia in 91% of patients with acute renal failure as a result of increase in urea and presence of oliguria.^[@CIT0012]^ In their study Fifty-three of the 56 patients had a mild anemia (hematocrit \< 35%) during their hospital stay. This finding is compatible with our finding that a majority of our patients (87.5%) with acute renal failure had a hematocrit below 35 percent. In the study of Michele Hales, Forty-three of the patients had a hematocrit below 30%, but this finding was not observed in our patients and only 12.5 percent of patients had a hematocrit lower than 30 percent. The probable cause of this discrepancy is the serum urea level. Because Michele Hales et al., found a significant correlation between maximum serum urea and severity of anemia thus a higher serum urea in their patients in comparison with our patients can be the reason of a higher percent of patients with lower hematocrit level.^[@CIT0012]^

Our study also revealed that acute renal failure did not cause significant thrombocytopenia and even platelet count in these patients were slightly higher in comparison to control group.

About patients with chronic renal failure we found that patients were anemic and most RBC indices including red blood cell count, Hb level, HCT concentration and MCHC level were significantly lower in comparison with the control group (P \< 0.05).

Our findings were compatible with a similar study that was done in 1979 by HW Radtke et al., and this study showed the development of anemia in patients at different stages of chronic renal failure.^[@CIT0011]^ In their patients the anemia was exaggerate during progression of renal insufficiency in patients at different stages of chronic renal failure.

Results of our study were in accordance with another study that was done in 2004 revealed the presence of anemia in 47.7% of 5222 patients with chronic renal failure before dialysis. It also showed the increased prevalence of anemia as kidney function decreased.^[@CIT0014]^ They also assess the glomerular filtration rate of patients and found that prevalence of anemia was strongly associated with declining glomerular filtration rate but we did not assess our patients from this aspect.

Another important finding of our study was that platelet count was statistically significant lower than healthy individuals (P \< 0.0001). Although the mean platelet (172.4×103/µl) count did not show that our patients have not in a potential bleeding risk but thrombocytopenia was an important risk factor for occurrence of bleeding among a minority of our study patients.

Study of Gafter U et al., in 1987 was done on the platelet count in 55 patients with end-stage renal failure on maintenance hemodialysis and in 19 predialysis patients with CRF before hemodialysis. This study showed the decrease of platelet count and mild thrombocytopenia in patients with CRF.^[@CIT0013]^

Another similar study was done between 12/2009_2/2010 and revealed that the patients with renal failure are at high risk of bleeding due to thrombocytopenia and platelet dysfunction.^[@CIT0015]^ In our study also we found a mild thrombocytopenia among our patients but only a minority of patients (8%) had a platelet count that would put patients at risk of bleeding.
